PitchBook
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid
Global biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the pre-pandemic peak seven years ago. Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking so far in 2026 amounted to $106 billion over 201 deals, according to PitchBook data. If the current pace of biopharma M&A holds up for the rest of the year, the industry could be on track to notch more than $250 billion in...
OpenAI and Anthropic May Be Rivals, but Investors Aren’t Picking Sides
OpenAI and Anthropic have battled for workers, customers, and public attention. The rival AI labs have been on opposite sides of policy proposals, and their CEOs were the only ones not to link hands among a dozen industry leaders at a business summit earlier this year. But they do have one big area of overlap: their investors.
'Disrupted or dead': AI is crushing a generation of startups built before ChatGPT
Five years ago, venture capitalists were pouring money into American startups selling everything from lingerie subscriptions to scheduling software, anointing them with billion-dollar valuations before most even turned a profit. It was a frothy era for startups, fueled by a combination of cheap money and pandemic-boosted demand. But even after the Federal Reserve took some froth off by starting to raise interest rates in 2022, many founders believed that they could grow into their inflated...
Commentary: SpaceX’s capital needs are out of this world
Commentary: SpaceX’s capital needs are out of this world SpaceX's rising capital needs might be a tough sell ahead of its blockbuster initial public offering, says Chris Bryant for Bloomberg Opinion. Elon Musk’s SpaceX needed comparatively little money to build a world-beating space launch and satellite-broadband firm. But as it reframes itself partly as an artificial-intelligence (AI) infrastructure company - offering both terrestrial and potentially space-based computing capacity - its...
Why Anthropic has edge over OpenAI in IPO race
Why Anthropic has edge over OpenAI in IPO race June 9, 2026It has all the ingredients of a Hollywood script: two ambitious tech nerds locked in a high-stakes battle for dominance in artificial intelligence (AI), complete with surprising plot twists. Take Dario Amodei, CEO of Anthropic, who recently called on the AI industry to pause development, warning that humanity could lose control of the technology. What made the statement remarkable was its timing: just days earlier, his company had...
Elon Musk Is Dropping a Boulder in a Kiddie Pool
Elon Musk is about to set in motion a chain of events that will reshape the global financial order. For starters, when SpaceX formally goes public next week, he is all but guaranteed to become the world’s first trillionaire. His rocket company is targeting a valuation of $1.77 trillion, which would make it one of the 10 biggest companies in the world—bigger than Meta, Walmart, and, for that matter, Tesla.
Why Anthropic has the edge over OpenAI in IPO race
Why Anthropic has the edge over OpenAI in IPO race June 9, 2026It has all the ingredients of a Hollywood script: two ambitious tech nerds locked in a high-stakes battle for dominance in artificial intelligence (AI), complete with surprising plot twists. Take Dario Amodei, CEO of Anthropic, who recently called on the AI industry to pause development, warning that humanity could lose control of the technology. What made the statement remarkable was its timing: just days earlier, his company...
Blacklisted AI company Anthropic, White House ease tensions ahead of IPO, sources say
Blacklisted AI company Anthropic, White House ease tensions ahead of IPO, sources say June 5 : A months-long dispute between Trump administration officials and AI firm Anthropic is showing signs of easing across parts of the U.S. government as the company prepares to go public, according to sources familiar with the relationship. The relationship ruptured earlier this year after Anthropic refused to allow the U.S. military to use its AI models for domestic surveillance and fully autonomous...
Nvidia picks Unitree for humanoid robot platform as Chinese startup eyes IPO
Nvidia has selected Chinese humanoid robot maker Unitree for the first robotics system the U.S. chipmaker is selling to researchers from Stanford to ETH Zurich, the company announced Monday. The system combines Unitree's nearly 6-foot-tall H2 humanoid robot with Nvidia's Jetson Thor hardware, which includes the company's advanced Blackwell GPU for on-device artificial intelligence capabilities. Nvidia's humanoid-focused AI models, known as Isaac GR00T, and simulation systems are part of the...
UK's GSK to acquire U.S. drugmaker Nuvalent for $10.6 billion as pharma giants race to expand pipelines
U.K. pharmaceutical group GSK has entered an agreement to acquire U.S.-based drugmaker Nuvalent for $10.6 billion to bolster its lung cancer pipeline, in what would be the British drugmaker's largest acquisition in more than a decade. The all-cash deal values Nuvalent at about $124 per share, according to a GSK filing on Tuesday, representing a 40% premium to its last closing price. The Financial Times had reported the transaction earlier on Tuesday.